Shalom Lerrer

695 total citations
17 papers, 507 citations indexed

About

Shalom Lerrer is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Shalom Lerrer has authored 17 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Shalom Lerrer's work include Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (6 papers). Shalom Lerrer is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (6 papers). Shalom Lerrer collaborates with scholars based in United States, Israel and Germany. Shalom Lerrer's co-authors include Adit Ben‐Baruch, Tsipi Meshel, Yulia Liubomirski, Stefan Wiemann, Cindy Körner, Dina Morein, Adam Mor, Kieran Adam, Rotem Feniger-Barish and Alexander Bott and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

Shalom Lerrer

17 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shalom Lerrer United States	9	278	226	202	122	51	17	507
Emilie Laprévotte France	9	283 1.0×	347 1.5×	188 0.9×	116 1.0×	34 0.7×	13	648
Ihor Arkhypov Germany	10	286 1.0×	402 1.8×	228 1.1×	101 0.8×	63 1.2×	11	677
Samantha Lasser Germany	9	284 1.0×	427 1.9×	236 1.2×	105 0.9×	57 1.1×	11	697
Junya Ohtake Japan	10	296 1.1×	276 1.2×	192 1.0×	68 0.6×	54 1.1×	18	524
Maria Corallo Italy	8	300 1.1×	106 0.5×	182 0.9×	83 0.7×	35 0.7×	11	455
Naoshi Kawamura Japan	10	233 0.8×	204 0.9×	156 0.8×	57 0.5×	46 0.9×	12	456
Natalie McGregor United States	8	240 0.9×	140 0.6×	224 1.1×	98 0.8×	85 1.7×	8	504
Mieke C. Zwager Netherlands	5	222 0.8×	244 1.1×	171 0.8×	87 0.7×	59 1.2×	10	425
Mariano F. Zacarías Fluck Spain	8	236 0.8×	186 0.8×	176 0.9×	87 0.7×	35 0.7×	15	463

Countries citing papers authored by Shalom Lerrer

Since Specialization

Citations

This map shows the geographic impact of Shalom Lerrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shalom Lerrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shalom Lerrer more than expected).

Fields of papers citing papers by Shalom Lerrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shalom Lerrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shalom Lerrer. The network helps show where Shalom Lerrer may publish in the future.

Co-authorship network of co-authors of Shalom Lerrer

This figure shows the co-authorship network connecting the top 25 collaborators of Shalom Lerrer. A scholar is included among the top collaborators of Shalom Lerrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shalom Lerrer. Shalom Lerrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Bukhari, Shoiab, Kieran Adam, Shalom Lerrer, et al.. (2024). Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity. Journal for ImmunoTherapy of Cancer. 12(3). e008482–e008482. 4 indexed citations

Lerrer, Shalom, et al.. (2024). Exclusion of PD-1 from the immune synapse: A novel strategy to modulate T cell function. SHILAP Revista de lepidopterología. 32(3). 200839–200839. 2 indexed citations

Bukhari, Shoiab, Shalom Lerrer, Robert Winchester, et al.. (2024). PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis. Arthritis Research & Therapy. 26(1). 32–32. 6 indexed citations

Gartshteyn, Yevgeniya, Laura Geraldino‐Pardilla, Shoiab Bukhari, et al.. (2024). SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis. Frontiers in Immunology. 15. 1327437–1327437. 4 indexed citations

Bukhari, Shoiab, Brian S. Henick, Robert Winchester, et al.. (2022). Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors. Cell Reports Medicine. 4(1). 100868–100868. 41 indexed citations

Lerrer, Shalom, Anna S. Tocheva, Shoiab Bukhari, Kieran Adam, & Adam Mor. (2021). PD-1-stimulated T cell subsets are transcriptionally and functionally distinct. iScience. 24(9). 103020–103020. 11 indexed citations

Strazza, Marianne, Kieran Adam, Shalom Lerrer, et al.. (2021). SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function. Inflammation. 44(4). 1529–1539. 15 indexed citations

Tocheva, Anna S., Michael Peled, Marianne Strazza, et al.. (2020). Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions. Journal of Biological Chemistry. 295(52). 18036–18050. 21 indexed citations

Tocheva, Anna S., Shalom Lerrer, & Adam Mor. (2020). In Vitro Assays to Study PD‐1 Biology in Human T Cells. Current Protocols in Immunology. 130(1). e103–e103. 6 indexed citations

10.

Lerrer, Shalom & Adam Mor. (2019). Immune checkpoint inhibitors and the shared epitope theory: from hypothesis to practice. Translational Cancer Research. 8(Suppl 6). S625–S627. 4 indexed citations

11.

Liubomirski, Yulia, Shalom Lerrer, Tsipi Meshel, et al.. (2019). Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer. Frontiers in Immunology. 10. 757–757. 138 indexed citations

12.

Liubomirski, Yulia, Shalom Lerrer, Tsipi Meshel, et al.. (2019). Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Frontiers in Immunology. 10. 804–804. 49 indexed citations

13.

Ben‐Baruch, Adit, et al.. (2019). E-103 Inflammation-driven networks in the regulation of breast cancer progression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(1). 41–41. 1 indexed citations

14.

Strazza, Marianne, Kieran Adam, Alan V. Smrcka, Shalom Lerrer, & Adam Mor. (2019). PLCε1 suppresses tumor growth by regulating murine T cell mobilization. Clinical & Experimental Immunology. 200(1). 53–60. 3 indexed citations

15.

Lerrer, Shalom, Yulia Liubomirski, Alexander Bott, et al.. (2017). Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells. Frontiers in Immunology. 8. 479–479. 28 indexed citations

16.

Bott, Alexander, Shalom Lerrer, Agnes Hotz‐Wagenblatt, et al.. (2017). miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A. Oncotarget. 8(27). 43897–43914. 65 indexed citations

17.

Lerrer, Shalom, Yulia Liubomirski, Leonor Leider–Trejo, et al.. (2015). Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Stem Cell Research & Therapy. 6(1). 87–87. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact